Quadria Capital is one of Asia’s leading specialist healthcare focused private equity group based in Singapore investing in the high growth healthcare sectors of some of the world’s fastest growing economies in South Asia and Southeast Asia. To date, Quadria Capital has invested in 15 companies across six countries in the region, through three private equity vehicles, and has over US$ 1.5 billion of managed capital.
Quadria Capital’s key differentiator is its ability to leverage the deep healthcare operating experience and domain expertise of its team to drive tangible value creation at portfolio companies and help them emerge as regional industry leaders. Quadria Capital seeks to make meaningful, positive impact by increasing access to affordable, high quality healthcare to underserved populations that need it the most. Quadria Capital believes that responsible investment is critical to long term, sustainable value creation in the region, and that its goals of both “doing good” and “doing well” are not just compatible, but in fact mutually reinforcing.
Quadria Capital, through its Singapore based SPV, Helix Investments Pte Limited, has successfully concluded an investment deal in Concord Biotech Ltd. (“Concord”). Concord is one of India’s leading manufacturers of fermentation based biopharmaceutical APIs, focused on niche segmen... (more)
